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a single-nucleotide polymorphism (rs738409; C>G/I148M) 
in the patatin-like phospholipase domain containing 3 
( PNPLA3 , adiponutrin) gene, to be strongly associated with 
NAFLD. A meta-analysis of 16 studies demonstrated that 
homozygous carriers of  PNPLA3 I148M have on the average a 
73% higher liver fat content than weight-matched homozy-
gous carriers of the major allele ( 5 ). However, NAFLD as-
sociated with PNPLA3 I148M is distinct from obesity-associated 
common NAFLD, as it is not characterized by features of 
the metabolic syndrome such as hyperinsulinemia or dys-
lipidemia ( 1, 5 ). 
 In vitro assays using recombinant PNPLA3 have sug-
gested that the WT PNPLA3 (PNPLA3 WT ) hydrolyzes 
emulsifi ed triacylglycerol (TAG) and that the I148M sub-
stitution in PNPLA3 (PNPLA3 I148M ) abolishes this activity 
( 6–8 ). Moreover, the protein was shown to display a transa-
cylase activity ( 7 ), and to prefer oleic acid (18:1n-9) as the 
fatty acyl moiety ( 9 ). Opposing a putative role as a lipase, 
PNPLA3 is induced by glucose and insulin ( 10–12 ) and 
is a target gene of the lipogenic transcription factors 
SREBP-1c and the carbohydrate responsive element bind-
ing protein, ChREBP ( 13–16 ). Kumari et al. ( 17 ) suggested 
that the protein acts as lipogenic lysophosphatidic acid 
(LPA) acyltransferase, converting LPA to phosphatidic 
acid (PA), and that the I148M substitution increases this 
activity. Because PA acts as a precursor for both phospho-
lipids and TAGs, this provided an alternative explanation 
for the hepatic fat accumulation in the PNPLA3 I148M allele 
carriers. Even though PNPLA3 knockout mice have no 
metabolic phenotype ( 18, 19 ), Kumashiro et al. ( 20 ) re-
ported that reducing PNPLA3 in rat liver via RNA interfer-
ence prevented hepatic steatosis, an effect attributed to 
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ice-cold 0.25 M sucrose. An aliquot of 100   l was withdrawn for 
total cell protein analysis using the BCA assay (Thermo Fisher 
Scientifi c, Waltham, MA). The data for glycerolipid synthesis rep-
resents seven parallel cell cultures originating from two indepen-
dent labeling experiments [the TAG and phosphatidylcholine 
(PC) species profi les in both experiments were in general the 
same and are shown in detail for the fi rst experiment, supple-
mentary Tables I, II]. 
 For analysis of TAG hydrolysis, the cells were cultured on 6 cm 
dishes and transfected as described above, washed, and changed 
into growth medium supplemented with 5% delipidated FBS and 
5   M triacsin C (Enzo Life Sciences, Farmingdale, NY). After 0, 
6, or 24 h chase times in this medium, the cells were washed with 
PBS and scraped into 1 ml of ice-cold 0.25 M sucrose. 
 For analysis of TAG turnover, HuH7 cells in complete growth 
medium without antibiotics were transfected for 24 h as above 
and then labeled for 24, 48, or 72 h with 15   g/ml [D17]18:1n-9 
(71-1851; Larodan Fine Chemicals, Malmö, Sweden) using fat-
free BSA as a vehicle. The lipids were extracted, and the unlabeled 
and labeled TAG species detected by MS as detailed below. 
 Lipid extraction, MS, and GC of FAs 
 Cellular lipids were extracted according to Folch et al. ( 25 ) and 
dissolved in chloroform:methanol 1:2. Immediately before MS, 
1% NH 4 OH was added along with an internal standard mixture 
containing polar and neutral lipid species. The samples were in-
fused into an ion trap ESI mass spectrometer (Esquire-LC, Bruker-
Franzen Analytik, Bremen, Germany) and spectra recorded by 
employing both positive and negative ionization mode in the 
range of  m / z 500–1,000 ( 26 ). The unlabeled [M] and [ 13 C]glycer-
ol-labeled [M+3] ions were resolved by comparing the spectra of 
cell samples with or without labeling, and deconvolution into dif-
ferent peaks was performed by the best profi le fi tting available in 
LIMSA software ( 27 ). In addition, FA composition of total lipids 
was determined by GC as detailed in Käkelä et al. ( 28 ). In order to 
confi rm glycerolipid species structures, the precursor scans for the 
main acyl chains detected by GC were later recorded in ESI-MS/
MS experiments for TAGs (positive mode neutral loss scans for the 
FAs) and PCs (negative mode precursor scans for the FAs of PC 
formate adducts) using a triple quadrupole mass spectrometer 
(Agilent 6490 Triple Quad LC/MS with iFunnel Technology; Agi-
lent Technologies, Santa Clara, CA). The [D17]18:1n-9 incorpora-
tion into TAG and the following turnover were studied using the 
triple quadrupole equipment by scanning for the positive mode 
neutral loss of the unlabeled and deuterated 18:1n-9 moiety . 
 For analysis of DAGs and PAs by ion trap ESI-MS, cellular lipids 
were extracted using a modifi ed Bligh/Dyer procedure ( 29 ). First, 
800   l of ice-cold 0.1 N HCl:methanol (1:1) was added to each 
cell pellet and DAG 24:0 was inserted as an internal standard. Then 
400   l of ice-cold chloroform was added and the separated lower 
phase was collected, evaporated to dryness under nitrogen fl ow, 
and fi nally the original volume was restored by adding chloroform:
methanol (1:9). The mass spectra for the DAG species were re-
corded in the positive ionization mode over the range of  m / z 400–
750. The spectra for PA species were recorded over the range of 
 m / z 600–800 by using samples brought into chloroform:methanol 
(1:2) and using PA 34:0 as internal standard. 
 The ion trap ESI-MS spectra were processed by Bruker Daltonics 
(Billerica, MA) data analysis software and the triple quadrupole 
ESI-MS/MS spectra by Agilent Mass Hunter software. Individual 
lipid species were quantifi ed by using the internal standards and 
the LIMSA software ( 27 ). 
 Fluorescence microscopy 
 To analyze the subcellular distribution of PNPLA3, HuH7 cells 
were transfected for 48 h with plasmids encoding GFP- PNPLA3 WT 
decreased FA esterifi cation. In apparent contradiction 
with these fi ndings, the study by Pirazzi et al. ( 21 ) in human 
subjects showed a reduced rate of large TAG-rich VLDL se-
cretion in I148M carriers versus 148II homozygotes for any 
amount of liver fat, suggesting that PNPLA3 I148M represents a 
loss-of-function mutant that promotes hepatocyte TAG accu-
mulation via reduction of VLDL assembly, putatively by in-
hibiting the mobilization of TAG FAs. Li et al. ( 22 ) recently 
developed transgenic mice overexpressing WT human 
PNPLA3 or the I148M variant either in liver or adipose tissue. 
Expression of PNPLA3 I148M , but not the WT protein, in the 
liver recapitulated the fatty liver phenotype. The above-
mentioned metabolic studies suggested that the increase in 
hepatic TAGs associated with the I148M allele results from 
multiple changes in hepatic TAG metabolism. Both 
PNPLA3 WT and PNPLA3 I148M localize prominently on cyto-
plasmic lipid droplets (LDs) ( 6, 23 ). Thus, the mechanism by 
which PNPLA3 I148M causes NAFLD is still controversial. 
 In the present study, we examined the mechanisms by 
which PNPLA3 and its I148M variant modify the lipid con-
tent and composition of human hepatic cells in vitro. We 
acutely overexpressed PNPLA3 WT or PNPLA3 I148M in the 
HuH7 hepatoma cell line, which expresses no detectable 
endogenous PNPLA3, cultured the cells under stable iso-
tope labeling of TAGs with [ 13 C]glycerol, and performed 
turnover experiments with oleic acid (18:1n-9) labeled 
with 17 deuterium atoms ([D17]18:1n-9). Cellular TAGs, 
diacylglycerols (DAGs), and phospholipids were examined 
by MS. Further evidence of the functional difference be-
tween PNPLA3 WT and PNPLA3 I148M was obtained by com-
paring their subcellular distributions in the presence or 
absence of FA supplementation. 
 MATERIALS AND METHODS 
 Cell culture 
 HuH7 cells ( 24 ) were grown in MEM (GIBCO/Life Tech-
nologies, Carlsbad, CA), containing 10% FBS, 2 mM  L -glutamine, 
100 U/ml penicillin, and 100   g/ml streptomycin. 
 cDNA constructs and antibodies 
 The  PNPLA3 cDNA open-reading frame corresponding to 
NM_025225 was isolated by PCR from human subcutaneous adi-
pose tissue and inserted into the  Eco RI site of pcDNA4HisMaxC (In-
vitrogen/Life Technologies) and pEGFP-C2 (Clontech/Takara Bio, 
Mountain View, CA). The I148M substitution corresponding to the 
rs738409 G allele was introduced in the  PNPLA3 cDNA with the 
Quikchange site-directed mutagenesis kit (Stratagene, La Jolla, 
CA). Rabbit anti-PNPLA3, anti-  -actin (Sigma-Aldrich, St. Louis, 
MO), and anti-green fl uorescent protein (GFP) (Life Technologies, 
Grand Island, NY) were employed for detection of Western blots. 
 PNPLA3 overexpression and treatments of cells 
 For analysis of preexisting and newly synthesized glycerolipids, 
HuH7 cells cultured on 6-well plates were transfected with an 
empty vector,  PNPLA3 WT , or  PNPLA3 I148M -pcDNAHisMaxC using 
Lipofectamine 2000 TM (Invitrogen). One day after transfection 
medium was changed to a labeling medium containing 500   g/ml 
of [ 13 C]glycerol (Cambridge Isotope Laboratories, Andover, MA), 
incubated for 24 h, washed with PBS, and scraped into 1 ml of 
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of 53 kDa) detectable by Western blot analysis ( Fig. 1A ). 
After 24 h of transfection, the cells were subjected to 24 h 
metabolic labeling of glycerolipids with [ 13 C]glycerol, and 
the cellular lipids were thereafter analyzed by MS. After 
the [ 13 C]glycerol labeling (total transfection time of 48 h), 
the cells expressing PNPLA3 I148M displayed a marked net 
increase of unlabeled TAGs compared with mock-
transfected controls, while expression of PNPLA3 WT had no 
such effect ( Fig. 1B ). While the unlabeled TAGs represent 
lipids that were present in the cells already before the label-
ing, the [ 13 C]TAGs represent the newly synthesized spe-
cies. After 48 h of transfection, the concentrations of [ 13 C]
TAGs were similar in controls and cells expressing either 
form of PNPLA3 ( Fig. 1C ), suggesting that PNPLA3 does 
not primarily enhance de novo TAG synthesis. Consistent 
with earlier fi ndings ( 6, 15 ), when the cells were incubated 
for 6 or 24 h in a medium supplemented with 5% delipi-
dated serum and the long chain FA-CoA synthase inhibi-
tor Triacsin C, PNPLA3 I148M caused a kinetic delay in TAG 
hydrolysis (data not shown). Thus, PNPLA3 I148M expression 
results in net TAG accumulation in the absence of altered 
synthesis of TAGs, but with a delay in their hydrolysis. 
 PNPLA3 induces redistribution of FAs between TAGs 
and membrane phospholipids 
 To analyze in detail the effect of PNPLA3 on the hepa-
tocellular glycerolipid dynamics, we studied the lipid spe-
cies profi les of the [ 13 C]glycerol-labeled cells (values for 
the glycerolipid species from the experiment described in 
 Fig. 2 are listed in supplementary Tables I–IV). According 
to PCA, the TAG profi les of both PNPLA3 WT and 
PNPLA3 I148M cells were found to differ signifi cantly from 
those of the controls ( Fig. 2A ). The most important prin-
cipal component extracted (PC1) explained 35% of the 
TAG variation between the constructs and refl ected the 
degree of FA unsaturation. Cells expressing either form of 
PNPLA3 were characterized by increased relative amounts 
of TAGs with saturated FA (SFA) and MUFA moieties. The 
WT and I148M cells differed with respect to principal 
or GFP-PNPLA3 I148M by using Lipofectamine 2000. Prior to fi xation 
with 4% paraformaldehyde, cells were treated for indicated times 
with 200   M oleic acid-BSA as described ( 30 ). For LD visualiza-
tion, cells were stained immediately after fi xation with LipidTox 
Red (Invitrogen/Life Technologies) according to the manufac-
turer’s instructions and imaged with a TCS SP2 confocal micro-
scope (Leica, Wetzlar, Germany). The percentage of cells exhibiting 
predominantly reticular/cytosolic PNPLA3 distribution was de-
termined by visual inspection of cells from 10 randomly selected 
fi elds under a wide-fi eld AX70 microscope (Olympus, Hamburg, 
Germany). 
 Statistical analysis of lipid levels 
 For univariate comparisons of the cellular lipid levels, statisti-
cal signifi cance for the differences between control, PNPLA3 WT , 
and PNPLA3 I148M overexpressing samples were assessed by using 
one-way ANOVA followed by Newman-Keuls test of means (SPSS 
Statistics, IBM, North Castle, NY). For multivariate comparisons 
of detailed lipid profi les, principal component analysis (PCA) 
(Sirius, PRS, Bergen, Norway) was used. The PCA describes com-
positional differences between the samples, and highlights the 
lipid species mainly responsible for the variation in the data. PCA 
was computed using arcsine transformed data and the relative 
positions of the samples and variables were plotted using the fi rst 
two principal components. In addition, quantitative multivariate 
measures of the compositional differences among the sample 
groups were determined by soft independent modeling of class 
analogy (SIMCA; Sirius) ( 31 ). To analyze the rate of TAG remod-
eling, regression lines of groups were compared by measuring the 
effect of a categorical factor on the responding variable, by using 
the ‘aov’ function in the ‘stats’ package of R. The statistical differ-
ences in the proportion of cells where PNPLA3 was present in 
cytosol or endoplasmic reticulum (ER) were tested by Student’s 
 t -test. 
 RESULTS 
 PNPLA3 I148M induces net TAG accumulation 
 We acutely overexpressed PNPLA3 WT or PNPLA3 I148M in 
the hepatoma cell line HuH7, which contains no endoge-
nous PNPLA3 protein (with an apparent molecular mass 
 Fig.  1. Overexpression of PNPLA3 I148M in HuH7 cells induces net TAG accumulation but does not affect the newly synthesized TAGs. A: 
Western analysis of mock-transfected controls and cells overexpressing PNPLA3 WT or PNPLA3 I148M . Beta-actin was probed as a loading 
control. B: Quantity of total unlabeled TAGs after 24 h of [ 13 C]glycerol labeling, analyzed by MS. C: Newly synthesized [ 13 C]glycerol-labeled 
TAGs after 24 h of labeling. The values for panels (B) and (C) originating from separate experiments were normalized by setting the 
PNPLA3 WT average of each experiment to 1. Means with no common letter differ at  P < 0.05 (one-way ANOVA followed by Newman-Keuls 
test of means). Error bars, SD; n = 7. Ctrl, control. 
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not shown). When applied for DAG species, the PCA fol-
lowed by SIMCA ( P < 0.05) showed that the profi le of 
PNPLA3 I148M -expressing cells was signifi cantly different from 
those of the controls and the PNPLA3 WT cells: the I148M 
cells were enriched with species containing SFAs or 
MUFAs. PNPLA3 WT cells localized in the PCA between the 
PNPLA3 I148M and control cells, and did not differ in SIMCA 
from the latter ( Fig. 2B ). The total cellular DAG content 
was unaffected by PNPLA3 WT /PNPLA3 I148M expression. 
 Analysis of the species profi les of cellular PCs, the major 
membrane phospholipid class of mammalian hepatocytes, 
showed a signifi cant shift (SIMCA,  P < 0.05) toward spe-
cies carrying PUFAs in both PNPLA3 WT - and PNPLA3 I148M -
transfected cells, especially arachidonic acid (20:4n-6) (e.g., 
component 2 (PC2) (explaining 23% of the variation), a 
component infl uenced by the presence/absence of [ 13 C]
glycerol in certain TAG species. PNPLA3 WT cell TAGs 
(high position on PC2 axis) contained, e.g., more newly 
synthesized [ 13 C]52:1 and [ 13 C]50:1 species (52:1H and 
50:1H in  Fig. 2A ) and less of their unlabeled counterparts 
than the I148M cells (low on PC2 axis). This observation is 
consistent with a more active remodeling of these TAGs in 
cells expressing the PNPLA3 WT as compared with the 
PNPLA3 I148M cells. The differences between the cells (con-
trol, WT, and I148M) seen on the PCA biplot were studied 
quantitatively by the SIMCA method, which confi rmed 
that the TAG profi les of the three transfected cell pools 
signifi cantly differed from each other ( P < 0.05, test graphics 
 Fig.  2. PCA reveals lipidome differences in HuH7 cells overexpressing PNPLA3 WT or PNPLA3 I148M . The samples located on the plot far-
thest from the origin (cross) on one side are relatively enriched in the lipid species farthest on the same side. The larger the distance of 
any two samples on this plot the more they differ in terms of the whole lipid species profi le. A: PCA of TAG species after 24 h of [ 13 C]glyc-
erol labeling. Species present in any of the cells at >0.5% were used as variables. Lipid species abbreviations: 56:3H = 56 carbons, 3 double 
bonds, [ 13 C]glycerol labeled, i.e., heavier (H) species; 52:4 = 52 carbons, 4 double bonds, unlabeled. C, control; W, PNPLA3 WT ; M, 
PNPLA3 I148M . Means with no common letter differ at  P < 0.05 (one-way ANOVA followed by Newman-Keuls test of means). B: PCA of DAGs. 
DAG species present at >0.5% were used as variables. C: PCA of PCs. PC species present with >0.5% were used as variables; a = alkyl-acyl species 
(commonly diacyl species). D: PCA of PAs. PA species present at >1% were used as variables. The total amounts of each lipid class (the major 
classes, TAG and PC, are displayed in pmol/  g cell protein and the minor classes, DAG and PA, in mol/mol total lipid) are shown as inserts; 
in (A) the hatched bottom part of the bars indicates the share of [ 13 C]-labeled TAGs . The bar graph statistics are as in  Fig. 1 . Ctrl, control. 
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diffuse cytosolic/ER distribution being detectable only in 
24% of the cells ( Fig. 4A, B ). Loading of the cells for 24 h 
with 18:1n-9 to enhance TAG synthesis resulted in an in-
crease of the LD association of both PNPLA3 WT and 
PNPLA3 I148M ( Fig. 4A, B ), suggesting that the lipid content 
and/or metabolic status of the LDs modulates PNPLA3 as-
sociation with these organelles. Of note, Western analysis 
of the cells verifi ed that both the GFP-PNPLA3 WT and the 
GFP-PNPLA3 I148M fusion proteins remained intact and 
were expressed at similar levels ( Fig. 4C ). 
 DISCUSSION 
 The mechanism of PNPLA3 function and the reasons 
for hepatic TAG accumulation in carriers of the I148M al-
lele are the subject of vivid debate. While PNPLA3 has 
been suggested to act either as a TAG lipase ( 6, 21 ) or as a 
lipogenic LPA acyltransferase ( 17 ), the present study em-
ploying a cultured human hepatocyte model provides evi-
dence for a more complex mode of PNPLA3 action in 
hepatocyte TAG remodeling, an activity that is partially in-
hibited in the I148M variant. The key observations sup-
porting this interpretation are:  i ) PNPLA3 WT overexpression 
causes no signifi cant net reduction of cellular TAGs;  ii ) 
PNPLA3 I148M induces net accumulation of TAGs and slows 
down TAG hydrolysis upon cellular lipid depletion ( 6, 15 ); 
 iii ) Both PNPLA3 WT and PNPLA3 I148M induce cellular en-
richment of SFA- and MUFA-containing TAGs, and simul-
taneously enrichment of PCs with PUFAs;  iv ) Upon [ 13 C]
glycerol labeling, PNPLA3 WT is associated with cellular en-
richment of newly synthesized [ 13 C]TAG species having 
52 or 50 acyl carbons and carrying one or several 18:1n-9 
FAs, whereas PNPLA3 I148M associates with the correspond-
ing unlabeled TAGs;  v ) Upon [D17]18:1n-9 labeling in 
36:4, 38:5, and 38:4), while the total cellular PC content did 
not differ signifi cantly between the control and PNPLA3 WT /
PNPLA3 I148M -transfected cells ( Fig. 2C ). Regarding the com-
position of PC species, cells transfected with either of the 
 PNPLA3 constructs differed signifi cantly (SIMCA,  P < 0.05) 
from the controls, and the PNPLA3 WT induced a more 
pronounced shift in the PC species composition than 
PNPLA3 I148M ( Fig. 2C ). This result, in the face of TAGs 
enriched with SFAs and MUFAs, suggests net transfer of 
PUFAs from TAGs to membrane phospholipids by the pro-
tein. The same phenomenon was seen in two independent 
experiments (data of the repeat experiment not shown). 
In extended cultures beyond 72 h, the FA composition of 
the PNPLA3 I148M -expressing cells was also slightly altered. 
The relative amounts of MUFAs 18:1n-7 and 16:1n-7 (vac-
cenic and palmitoleic acids, respectively) were signifi cantly 
increased as compared with the controls or PNPLA3 WT -
transfected cells (ANOVA,  P < 0.05; supplementary Table V). 
 PNPLA3 overexpression has no impact on 
hepatocellular PAs 
 Prompted by the report of Kumari et al. ( 17 ) suggest-
ing that PNPLA3 displays LPA acyltransferase activity, 
we analyzed the PA contents and species profi les in the 
transfected HuH7 cells. The PA patterns of PNPLA3 WT /
PNPLA3 I148M -expressing cells or the total cellular amount of 
PAs did not differ signifi cantly from the controls ( Fig. 2D ). 
 PNPLA3 WT , but not PNPLA3 I148M , enhances the 
remodeling of TAGs 
 To directly assess the possibility that PNPLA3 facilitates the 
remodeling of hepatocyte TAGs, we carried out labeling of 
transfected HuH7 cells in serum containing growth medium 
with stable isotope [D17]18:1n-9, the preferred substrate of 
PNPLA3 ( 9 ), for 24, 48, or 72 h, followed by lipid extraction 
and mass spectrometric analysis of the TAGs. At the 24 h time 
point, analysis of the relative amount of [D17]-labeled versus 
unlabeled 18:1-containing TAGs revealed a signifi cant in-
crease of [D17]18:1n-9 incorporation into TAGs in cells ex-
pressing PNPLA3 WT , an effect not observed with PNPLA3 I148M 
( Fig. 3 ). After this time point, the relative amount of [D17]
TAGs reduced in PNPLA3 WT -expressing cells more rapidly as 
compared with PNPLA3 I148 or the mock-transfected control 
( P < 0.01), all three groups of transfected cells ending up at 
the same level at the 72 h time point ( Fig. 3 ). These observa-
tions suggest that PNPLA3 WT enhances both 18:1n-9 incorpo-
ration into TAGs and its removal from these lipids, a 
remodeling activity defective in PNPLA3 I148M . 
 PNPLA3 I148M localizes more extensively to LDs than the 
WT protein 
 To assess the subcellular distribution and the putative 
impact of PNPLA3 on LD morphology, we expressed the 
GFP-tagged WT or I148M proteins in HuH7 cells, followed 
by LD visualization with the LipidTox Red dye ( Fig. 4 ). In 
most cells PNPLA3 associated with LDs, but 46% of the 
cells exhibited, in addition, a more diffuse pattern, most 
likely refl ecting cytosolic and ER distribution. Interest-
ingly, PNPLA3 I148M associated more faithfully with LDs, a 
 Fig.  3. PNPLA3 WT , but not PNPLA3 I148M , enhances the hepato-
cellular remodeling of TAGs. HuH7 cells transfected with empty 
vector (Ctrl) or the indicated PNPLA3 expression constructs were 
labeled in complete growth medium with [D17]18:1n-9 as speci-
fi ed in the Materials and Methods, followed by lipid extraction and 
mass spectrometric quantifi cation of TAG molecular species. The 
data represent the amount of [D17]18:1n-9-containing TAGs rela-
tive to the corresponding unlabeled species, a ratio which de-
creased rapidly for the PNPLA3 WT cells. The data points represent 
mean ± SD, n = 4–5, and the  P value indicates signifi cant difference 
between the regression models. 
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complete growth medium, PNPLA3 WT , but not PNPLA3 I148M , 
enhances the incorporation of this deuterated FA into 
TAGs during 24 h and speeds up its turnover during lon-
ger labeling times. Thus, even though PNPLA3 WT does not 
signifi cantly affect the total cellular TAG content, it has a 
distinct impact on the incorporation and removal of its 
preferred substrate fatty acyl moiety, 18:1n-9 ( 9 ), into/
from TAGs, an activity defective in PNPLA3 I148M . 
 The facts that the PNPLA3-induced alterations in mo-
lecular species composition observed in TAGs, DAGs, and 
PCs were not present in PAs, and that the total cellular PA 
content was not signifi cantly altered, suggest that PNPLA3 
may not signifi cantly modify lipid syntheses at the level of 
PA ( 17 ). However, unaltered PA steady state concentrations 
do not rule out dynamic changes of PA metabolism. In ear-
lier work with the same hepatic cell model, we found no 
signifi cant effect of PNPLA3 WT or PNPLA3 I148M on de novo 
lipogenesis as measured by [ 3 H]acetate labeling ( 15 ). 
 Acyl chain remodeling is considered a frequent process 
in hepatocytes, and in addition to acyltransferases, transacy-
lases are present that catalyze the acyl chain transfer ( 32, 
33 ). Our cell model data employing acute overexpression 
of PNPLA3 reveals that PNPLA3 has the capacity to modify 
the TAG, DAG, and PC FA composition. This could involve 
hydrolysis of TAG FA ester bonds, followed by activation of 
the released FAs by CoA and transfer to the FA scavenging 
acceptor lyso-PC to form PC ( 34 ) or to DAGs to resynthesize 
TAGs. Alternatively, PNPLA3 may catalyze or facilitate CoA-
independent direct FA transfer between lipids, designated 
transacylase activity ( 7 ). PNPLA3 has been shown to display 
both TAG lipase and transacylase activities in vitro ( 6–8 ). 
The present data are compatible with TAG remodeling via 
either of these routes. The observed enrichment of cellular 
TAGs with SFA- and MUFA-containing species suggests that 
the PNPLA3-associated remodeling activity exhibits FA se-
lectivity. However, PNPLA3 displays no fatty acyl-CoA DAG 
acyltransferase activity in vitro, suggesting that PNPLA3 
does not directly mediate FA reesterifi cation into TAGs ( 9 ). 
Instead, the transacylation activity assigned for PNPLA3 ( 7 ) 
may target selected FAs. The fact that PNPLA3 I148M associ-
ated in [ 13 C]glycerol labeling experiments with the preex-
isting unlabeled 52:1 and 50:1 TAGs and the WT protein 
with the corresponding newly synthesized species, the retar-
dation of TAG hydrolysis by PNPLA3 I148M , as well as the lack 
of effect by PNPLA3 I148M on [D17]18:1n-9 labeling of TAGs 
and turnover of the label, suggested that a hallmark prop-
erty of the NAFLD-associated PNPLA3 I148M is a defect in 
TAG remodeling. Because each cycle of FA ester hydrolysis 
and reesterifi cation results in a “leak” of FAs for oxidation, 
phospholipid synthesis, or VLDL assembly ( 32 ), such a de-
fect may eventually result in net TAG accumulation. In 
chronic long-term accumulation of large LDs rich in hydro-
phobic TAG species, the mobilization rate of TAG is further 
decelerated ( 35 ). Thus, altered TAG remodeling in cells 
expressing PNPLA3 I148M may generate LDs with a TAG 
composition resistant to hydrolysis. This interpretation is 
compatible with the complex phenotypic effects of human 
PNPLA3 I148M expressed in the liver of transgenic mice ( 22 ) 
and the published human data ( 21 ). 
 Fig.  4. PNPLA3 I148M localizes more extensively to LDs than 
PNPLA3 WT . A: HuH7 cells were transfected with GFP-PNPLA3 WT 
(WT) or -PNPLA3 I148M (I148M) in the absence (six top panels) 
or presence (six bottom panels) of 24 h treatment with 200   m 
oleic acid (OA), then fi xed and stained with LipidTox to visual-
ize LDs. The images are confocal and represent a single focal 
plane, Scale bars, 10   m. B: Quantifi cation of GFP-PNPLA3 WT or 
-PNPLA3 I148M distribution in the presence or absence of OA treat-
ment by fl uorescence microscopy analysis. The bars represent per-
centage of cells in the fi eld exhibiting predominantly an ER/
cytosolic staining pattern. Data are expressed as mean ± SEM; 
number of fi elds, 10 per treatment; number of cells, 89–127. * P < 
0.01, ** P < 0.001. C: Western analysis of the cells with anti-GFP, 
showing that the expressed fusion proteins are intact and pres-
ent at similar levels. 
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 PNPLA3 was recently shown to localize to LDs in both he-
patocytes ( 6 ) and fi broblast-like cells ( 23 ). Our morphologic 
observations in hepatic cells suggest that PNPLA3 I148M as-
sociates more extensively with LD surfaces than PNPLA3 WT . 
Moreover, FA loading of the hepatoma cells enhanced the 
association of both PNPLA3 WT and PNPLA3 I148M with the 
enlarged LDs. While the effect of PNPLA3 I148M on hepato-
cyte LD size has been established ( 6, 22, 23 ), its increased 
association with LDs is a novel observation. It is possible 
that upon FA loading, the increase in LD size, and in the 
amount of stored TAG are suffi cient to enhance PNPLA3 
association with the LDs, and that this effect is more pro-
nounced with PNPLA3 I148M which facilitates net TAG ac-
cumulation. On the other hand, the more extensive LD 
localization of PNPLA3 I148M may refl ect its altered function 
in TAG metabolism. It could, for instance, modify the re-
cruitment of cofactors regulating lipase or FA reesterifi ca-
tion activity on the LD surface ( 23 ). 
 PNPLA3 transcription is, similarly to a number of li-
pogenic genes, induced by refeeding glucose and insulin 
( 10–12 ), consistent with the notion that its function is not 
predominantly lipolytic. If PNPLA3 acts to control cycles 
of TAG remodeling, what would be the physiologic role of 
this activity? We fi nd it possible that, under conditions of 
insulin-induced lipogenesis, increased levels of PNPLA3 
are needed to maintain the dynamic metabolic properties 
of the rapidly growing LDs and selective sorting of FAs be-
tween the pools of storage and membrane lipids. 
 As a conclusion, our data suggests that PNPLA3 facili-
tates hepatic TAG remodeling in a FA-selective manner. 
The present fi ndings are consistent with a model in which 
PNPLA3 I148M induces a defect in TAG remodeling, result-
ing in hepatocellular TAG accumulation.  
 The authors are grateful to Liisa Arala, Eeva Jääskeläinen, Anne 
Salo, and Mia Urjansson for skilled technical assistance. 
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